SM
ALNA

Sabby Management’s Allena Pharmaceuticals ALNA Stock Holding History

Sabby Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-269,836
Closed -$345K – 202
2020
Q4 		$345K Buy
+269,836
New +$376K 0.07% 71
2020
Q3 		– Sell
-1,531,446
Closed -$2.42M – 157
2020
Q2 		$2.42M Buy
+1,531,446
New +$2.57M 0.49% 31

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sabby Management's ALNA Position: Q1 2021 in Review

Sabby Management sold out of Allena Pharmaceuticals (ALNA) in Q1 2021, closing a stake of 269,836 shares — an estimated $345K sold.

Sabby Management first reported a position in ALNA in Q2 2020 and held it in 2 quarters. The position peaked at $2.42M in Q2 2020. 30 funds tracked by Wall St. Rank hold ALNA as of Q1 2021.

  • Sabby Management reported no remaining Allena Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Sabby Management sold 269,836 Allena Pharmaceuticals shares in Q1 2021, an estimated $345K.
  • Sabby Management first reported a position in Allena Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Sabby Management's Allena Pharmaceuticals position peaked at $2.42M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2021.

Based on Sabby Management's 13F filing for Q1 2021, filed 17 May 2021.